Cited 0 times in Scipus Cited Count

Prognostic significance of tetraspanin CD151 in newly diagnosed glioblastomas.

DC Field Value Language
dc.contributor.authorLee, D-
dc.contributor.authorSuh, YL-
dc.contributor.authorPark, TI-
dc.contributor.authorDo, IG-
dc.contributor.authorSeol, HJ-
dc.contributor.authorNam, DH-
dc.contributor.authorKim, ST-
dc.date.accessioned2014-05-02T05:08:14Z-
dc.date.available2014-05-02T05:08:14Z-
dc.date.issued2013-
dc.identifier.issn0022-4790-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/9892-
dc.description.abstractBACKGROUND: Tetraspanin CD151 is a positive effector of cancer invasion and metastasis.
METHODS: We investigated the expression of CD151 by immunohistochemistry in 211 cases of grade I to IV gliomas. Additionally, we performed O6-methylguanin-DNA methyltransferase (MGMT) methylation analysis using real-time methylation-specific PCR in 36 patients with glioblastoma, and the prognostic significance of these biomarkers in glioblastomas was evaluated.
RESULTS: Overexpression of CD151 was observed in a significant proportion (55.6%) of glioblastomas, while CD151 was rarely overexpressed in most of grade I to III glial tumors. CD151 overexpression was closely associated with MGMT methylation (P = 0.014), and it was a prognostic factor for predicting worse overall survival (OS; P = 0.002) and progression-free survival (PFS; P = 0.043). We also found that combination of CD151 overexpression and MGMT methylation better stratified the patients' OS (P = 0.001) and PFS (P = 0.009). In multivariate analysis, CD151 overexpression was an independent prognostic factor for predicting OS over MGMT methylation (P = 0.012).
CONCLUSIONS: CD151 seems to have a critical role for high-grade progression in astroglial tumors. Furthermore, CD151 is a good tissue marker that can be used easily in a daily practice for predicting worse prognosis in patients with glioblastoma.
-
dc.formatapplication/pdf-
dc.language.isoen-
dc.subject.MESHAdult-
dc.subject.MESHAged-
dc.subject.MESHAntigens, CD151-
dc.subject.MESHBrain-
dc.subject.MESHBrain Neoplasms-
dc.subject.MESHCerebral Cortex-
dc.subject.MESHChemoradiotherapy, Adjuvant-
dc.subject.MESHDNA Methylation-
dc.subject.MESHFemale-
dc.subject.MESHFollow-Up Studies-
dc.subject.MESHGene Expression Regulation, Neoplastic-
dc.subject.MESHGlioblastoma-
dc.subject.MESHGlioma-
dc.subject.MESHHumans-
dc.subject.MESHImmunohistochemistry-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHMultivariate Analysis-
dc.subject.MESHO(6)-Methylguanine-DNA Methyltransferase-
dc.subject.MESHPrognosis-
dc.subject.MESHReal-Time Polymerase Chain Reaction-
dc.subject.MESHSurvival Analysis-
dc.subject.MESHTumor Markers, Biological-
dc.subject.MESHUp-Regulation-
dc.titlePrognostic significance of tetraspanin CD151 in newly diagnosed glioblastomas.-
dc.typeArticle-
dc.identifier.pmid22926763-
dc.contributor.affiliatedAuthor이, 다근-
dc.type.localJournal Papers-
dc.identifier.doi10.1002/jso.23249-
dc.citation.titleJournal of surgical oncology-
dc.citation.volume107-
dc.citation.number6-
dc.citation.date2013-
dc.citation.startPage646-
dc.citation.endPage652-
dc.identifier.bibliographicCitationJournal of surgical oncology, 107(6). : 646-652, 2013-
dc.identifier.eissn1096-9098-
dc.relation.journalidJ000224790-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Pathology
Files in This Item:
There are no files associated with this item.

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse